The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Selective removal of soluble tumor necrosis factor receptors by apheresis as a novel immunotherapy approach for triple-negative breast cancer.
 
Adam Ostrowski
Employment - Immunicom
Leadership - Immunicom
Honoraria - Immunicom
Consulting or Advisory Role - Immunicom
Research Funding - Immunicom
Travel, Accommodations, Expenses - Immunicom
 
Robert Segal
Employment - Immunicom
Leadership - Immunicom
Stock and Other Ownership Interests - Immunicom
Consulting or Advisory Role - Advent Therapeutics
Research Funding - Advent Therapeutics
 
Lawrence Florin
Employment - Immunicom
Leadership - Immunicom
Travel, Accommodations, Expenses - Immunicom
 
Nina Anderson
Employment - Immunicom
 
Victoria G. Manax
Employment - Immunicom
Leadership - Immunicom
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Immunicom
 
Annette Marleau
Employment - Immunicom
Leadership - Immunicom
Travel, Accommodations, Expenses - Immunicom
 
Steven Josephs
Employment - Immunicom
Leadership - Immunicom
Stock and Other Ownership Interests - Immunicom
Patents, Royalties, Other Intellectual Property - Patents pending through Immunicom
 
Piotr Jan Wysocki
Honoraria - AstraZeneca/Merck; Immunicom; Roche
Consulting or Advisory Role - AstraZeneca/Merck; Immunicom; Merck; Roche
Research Funding - Immunicom
Travel, Accommodations, Expenses - Immunicom
 
Kamil Wladyslaw Konopka
Research Funding - Immunicom
 
Lukasz Kwinta
Research Funding - Immunicom
 
Pawel Michal Potocki
Research Funding - Immunicom